Table 4.

Regimens for the eradication of Helicobacter pylori

Therapy and drug Dosage Frequency
 Triple therapy with bismuth subcitrate  
 Bismuth  120 mg  qid for 7 days 
 Tetracycline  500 mg  qid for 7 days  
 Metronidazole 500 mg  tid for 7 days  
Triple therapy with H2-receptor antagonists  
 Ranitidine  300 mg daily for 6-10 weeks  
 Metronidazole  500 mg  tid for 12 days  
 Amoxicillin  750 mg  tid for 12 days  
Triple therapy with acid-pump inhibitors  
 Omeprazole  20 mg bid for 7 days  
 Amoxicillin  1000 mg  bid for 7 days 
 Clarithromycin  500 mg  bid for 7 days 
Therapy and drug Dosage Frequency
 Triple therapy with bismuth subcitrate  
 Bismuth  120 mg  qid for 7 days 
 Tetracycline  500 mg  qid for 7 days  
 Metronidazole 500 mg  tid for 7 days  
Triple therapy with H2-receptor antagonists  
 Ranitidine  300 mg daily for 6-10 weeks  
 Metronidazole  500 mg  tid for 12 days  
 Amoxicillin  750 mg  tid for 12 days  
Triple therapy with acid-pump inhibitors  
 Omeprazole  20 mg bid for 7 days  
 Amoxicillin  1000 mg  bid for 7 days 
 Clarithromycin  500 mg  bid for 7 days 

All of these schemes showed eradication rates of about 90%. Any antibiotic regimen that is effective in eradication of H pylorican be used in the initial treatment of MALT lymphoma. Thus far, no regimen has been proven to be superior in inducing lymphoma remissions. A second-line anti-Helicobacter therapy with different antibiotics may be needed in some instances. Patients allergic to penicillin may be given a tetracycline-based regimen.

or Create an Account

Close Modal
Close Modal